When the Food and Drug Administration (FDA) banned sales of all transvaginal mesh products for pelvic organ prolapse in April 2019, the ruling created a wave of confusion around a condition that’s often misunderstood.
Millions of women experience fecal incontinence – debilitating bowel leakage – with limited treatment options. Until now. PTNS, an innovative nerve therapy, might be a game-changer, and it’s only available through this clinical trial. Learn more.
